在急诊疑似肺栓塞患者中采用YEARS规则联合年龄校正D-二聚体阈值诊断策略对血栓栓塞事件的影响:一项随机临床试验
该研究为在法国和西班牙18个急诊科开展的整群随机交叉非劣效性试验,纳入1414例临床低危且PERC未排除或主观中危的疑似肺栓塞患者。干预组(726例)采用YEARS规则联合年龄校正D-二聚体阈值决定是否可不行胸部影像学检查排除肺栓塞;对照组(688例)仅用年龄校正D-二聚体阈值。主要终点为3个月静脉血栓栓塞(VTE),干预组1例(0.15% [95%CI, 0.0% to 0.86%])vs对照组5例(0.80% [95%CI, 0.26% to 1.86%]),校正差值-0.64%(单侧97.5%CI,-∞ to 0.21%),在非劣效界值1.35%以内。干预组胸部影像学检查比例(30.4% vs 40.0%;校正差值-8.7% [95%CI, -13.8% to -3.5%])和急诊中位停留时间(6小时 [IQR, 4 to 8小时] vs 6小时 [IQR, 5 to 9小时];校正差值-1.6小时 [95%CI, -2.3 to -0.9])均低于对照组。
要点
- 在18个急诊科、1414例疑似肺栓塞患者中,YEARS规则联合年龄校正D-二聚体阈值组3个月VTE为0.15%(95%CI 0.0% to 0.86%),对照组为0.80%(95%CI 0.26% to 1.86%),校正差值-0.64%(单侧97.5%CI,-∞ to 0.21%),在非劣效界值1.35%以内。
- 干预策略使胸部影像学检查比例从对照组的40.0%降至30.4%(校正差值-8.7% [95%CI, -13.8% to -3.5%])。
- 干预策略使急诊中位停留时间从对照组的6小时(IQR, 5 to 9小时)降至6小时(IQR, 4 to 8小时),校正差值-1.6小时(95%CI, -2.3 to -0.9)。
- 干预组排除肺栓塞的条件为:无YEARS标准且D-二聚体<1000 ng/mL;或有1项及以上YEARS标准且D-二聚体低于年龄校正阈值(<50岁为500 ng/mL,≥50岁为年龄×10)。
- 纳入人群为临床低危且PERC未排除或主观临床中危的疑似肺栓塞急诊患者。
适用人群与场景
- 法国和西班牙18个急诊科中,临床低危但PERC规则未排除、或主观临床中危的疑似肺栓塞患者,共1414例(平均年龄55岁,58%女性),纳入时间2019年10月至2020年6月,随访至2020年10月。
诊断标准与关键阈值
- 干预组排除肺栓塞的标准:无YEARS标准且D-二聚体<1000 ng/mL,或有1项及以上YEARS标准且D-二聚体低于年龄校正阈值(<50岁为500 ng/mL,≥50岁为年龄(岁)×10 ng/mL)。
- 对照组排除肺栓塞的标准:D-二聚体低于年龄校正阈值(<50岁为500 ng/mL,≥50岁为年龄(岁)×10 ng/mL)。
- 主要终点非劣效界值为1.35%。
处置流程与药物剂量
- 干预组:无YEARS标准且D-二聚体<1000 ng/mL者,或1项及以上YEARS标准且D-二聚体低于年龄校正阈值(<50岁为500 ng/mL,≥50岁为年龄×10 ng/mL)者,不行胸部影像学检查即排除肺栓塞。
- 对照组:D-二聚体低于年龄校正阈值(<50岁为500 ng/mL,≥50岁为年龄×10 ng/mL)者,不行胸部影像学检查即排除肺栓塞。
研究设计与关键结果
- 研究类型:整群随机交叉非劣效性试验,18个急诊科,纳入1414例疑似肺栓塞患者,干预组726例,对照组688例;符合方案分析1217例(86%)。
- 急诊诊断肺栓塞100例(7.1%)。
- 主要终点:3个月VTE干预组1例(0.15% [95%CI, 0.0% to 0.86%])vs对照组5例(0.80% [95%CI, 0.26% to 1.86%]),校正差值-0.64%(单侧97.5%CI,-∞ to 0.21%),在非劣效界值1.35%以内。
- 6个分析的次要终点中仅2个有统计学显著差异:胸部影像学检查干预组30.4% vs对照组40.0%(校正差值-8.7% [95%CI, -13.8% to -3.5%]);急诊中位停留时间干预组6小时(IQR, 4 to 8小时)vs对照组6小时(IQR, 5 to 9小时),校正差值-1.6小时(95%CI, -2.3 to -0.9)。
- 其他次要终点包括非必要抗凝治疗、全因死亡、3个月全因再入院等,原文报告共8个次要终点,其中6个被分析。
证据类型、等级与局限
- 证据类型:整群随机交叉非劣效性试验(RCT)。
对床旁实践的改变
- 作者认为,在PERC阳性的疑似肺栓塞急诊患者中,与常规诊断策略相比,YEARS规则联合年龄校正D-二聚体阈值并未导致更高的血栓栓塞事件发生率。
指南或共识出处
- 临床试验注册号:ClinicalTrials.gov NCT04032769。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Uncontrolled studies suggest that pulmonary embolism (PE) can be safely ruled out using the YEARS rule, a diagnostic strategy that uses varying D-dimer thresholds.
OBJECTIVE: To prospectively validate the safety of a strategy that combines the YEARS rule with the pulmonary embolism rule-out criteria (PERC) rule and an age-adjusted D-dimer threshold.
DESIGN, SETTINGS, AND PARTICIPANTS: A cluster-randomized, crossover, noninferiority trial in 18 emergency departments (EDs) in France and Spain. Patients (N = 1414) who had a low clinical risk of PE not excluded by the PERC rule or a subjective clinical intermediate risk of PE were included from October 2019 to June 2020, and followed up until October 2020.
INTERVENTIONS: Each center was randomized for the sequence of intervention periods. In the intervention period (726 patients), PE was excluded without chest imaging in patients with no YEARS criteria and a D-dimer level less than 1000 ng/mL and in patients with 1 or more YEARS criteria and a D-dimer level less than the age-adjusted threshold (500 ng/mL if age <50 years or age in years × 10 in patients ≥50 years). In the control period (688 patients), PE was excluded without chest imaging if the D-dimer level was less than the age-adjusted threshold.
MAIN OUTCOMES AND MEASURES: The primary end point was venous thromboembolism (VTE) at 3 months. The noninferiority margin was set at 1.35%. There were 8 secondary end points, including chest imaging, ED length of stay, hospital admission, nonindicated anticoagulation treatment, all-cause death, and all-cause readmission at 3 months.
RESULTS: Of the 1414 included patients (mean age, 55 years; 58% female), 1217 (86%) were analyzed in the per-protocol analysis. PE was diagnosed in the ED in 100 patients (7.1%). At 3 months, VTE was diagnosed in 1 patient in the intervention group (0.15% [95% CI, 0.0% to 0.86%]) vs 5 patients in the control group (0.80% [95% CI, 0.26% to 1.86%]) (adjusted difference, -0.64% [1-sided 97.5% CI, -∞ to 0.21%], within the noninferiority margin). Of the 6 analyzed secondary end points, only 2 showed a statistically significant difference in the intervention group compared with the control group: chest imaging (30.4% vs 40.0%; adjusted difference, -8.7% [95% CI, -13.8% to -3.5%]) and ED median length of stay (6 hours [IQR, 4 to 8 hours] vs 6 hours [IQR, 5 to 9 hours]; adjusted difference, -1.6 hours [95% CI, -2.3 to -0.9]).
CONCLUSIONS AND RELEVANCE: Among ED patients with suspected PE, the use of the YEARS rule combined with the age-adjusted D-dimer threshold in PERC-positive patients, compared with a conventional diagnostic strategy, did not result in an inferior rate of thromboembolic events.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04032769.
参考来源
- Freund Y, Chauvin A, Jimenez S, et al. Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism: A Randomized Clinical Trial. JAMA. 2021. PMID: 34874418. doi:10.1001/jama.2021.20750
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。